
Prescription Cocaine: Geneva's Pragmatic Cure or Ethical Capitulation?
A plan to provide cocaine to severe addicts sparks a fierce debate, pitting a new generation of harm-reduction advocates against one of the movement's own pioneers.

In the clean, orderly world of Swiss public health, some problems refuse to be managed with polite notices and well-funded awareness campaigns. Geneva, a city more accustomed to brokering peace than managing street-level degradation, is now confronting the grim reality of a burgeoning crack cocaine crisis. Addicts find themselves in a rapid, destructive cycle of acquiring funds, purchasing the drug, and consuming it, often forgoing food, water, and sleep for days. Traditional outreach is proving futile.
In response, Daniele Zullino, head of addiction medicine at the University Hospital of Geneva, is proposing a solution that is either brilliantly pragmatic or deeply misguided, depending on one's perspective. The plan is to establish a cocaine-assisted treatment program, directly analogous to the country's long-standing heroin prescription model. For the most severe cases, the state would provide the drug to be consumed in a controlled environment—specifically, in cabins equipped with powerful ventilation systems to contain every molecule. The goal is not to cure, but to manage; to break the criminal cycle and re-establish contact with a population that has fallen through every social safety net.
Yet, this seemingly logical next step in Swiss harm reduction has provoked a furious backlash from an unexpected quarter. André Seidenberg, a 75-year-old pioneer of the very heroin-assisted treatments that inspired the Geneva project, has filed a legal complaint against Zullino. Seidenberg argues the plan is fundamentally flawed, branding it both unethical and unlawful. He contends that the medical case for prescribing a stimulant like cocaine is far weaker than for opioids, and that proponents have failed to demonstrate that the benefits would outweigh the significant harm. For a veteran of Switzerland's drug policy wars to turn against his ideological successors is a remarkable development.
Zullino counters that while the approach carries risks, it is demonstrably less dangerous than the alternative, which is leaving addicts to fend for themselves on the street. Unlike with heroin, no substitute medication for crack addiction exists, making direct prescription a potential, if controversial, option for the most desperate cases. The debate is not confined to Geneva; Zurich's health department is also working on a similar study, indicating a nationwide search for answers.
Meanwhile, the national addiction monitoring body, Sucht Schweiz, has published data showing a clear upward trend in cocaine and crack consumption. The pressure on policymakers is mounting. Geneva now finds itself at the forefront of a difficult national conversation. It is a classic Swiss dilemma, pitting a desire for technocratic, managed solutions against profound ethical questions. The city must now determine whether its famed pragmatism has its limits, or if it is willing to prescribe a poison in order to save a life.
Written by Thorben Thiede thorben.thiede@alpineweekly.com




